Status:
COMPLETED
Identification of Novel Targets for Regulation of Adipose Tissue Mass
Lead Sponsor:
Gottfried Rudofsky
Collaborating Sponsors:
Swiss Federal Institute of Technology
Conditions:
Obesity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to understand the metabolic changes occurring in fat tissue both during controlled weight loss that lead to the improvement of type 2 diabetes and other obesity associated met...
Eligibility Criteria
Inclusion
- Participants of the OPTIFAST52 program
- BMI \> 30 kg/m2
Exclusion
- Rejection of informed consent by the participant
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT00773565
Start Date
October 1 2008
End Date
August 1 2011
Last Update
August 23 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Heidelberg
Heidelberg, Germany, 69115